Sunbelt Securities’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
5,357
-137
-2% -$26.4K 0.07% 245
2025
Q4
$1.01M Sell
5,494
-38
-0.7% -$6.67K 0.07% 245
2025
Q3
$849K Sell
5,532
-281
-5% -$42.5K 0.06% 276
2025
Q2
$762K Buy
5,813
+71
+1% +$9.95K 0.07% 253
2025
Q1
$844K Sell
5,742
-71
-1% -$10.3K 0.08% 219
2024
Q4
$762K Buy
5,813
+1,943
+50% +$272K 0.07% 254
2024
Q3
$603K Buy
3,870
+18
+0.5% +$2.91K 0.06% 310
2024
Q2
$601K Buy
3,852
+3,645
+1,761% +$548K 0.06% 292
2024
Q1
$28K Sell
207
-26
-11% -$3.44K ﹤0.01% 1017
2023
Q4
$31.3K Sell
233
-13
-5% -$1.69K ﹤0.01% 912
2023
Q3
$33.3K Buy
246
+13
+6% +$1.78K ﹤0.01% 895
2023
Q2
$33.3K Sell
233
-9
-4% -$1.32K ﹤0.01% 889
2023
Q1
$33.4K Buy
+242
New +$32.6K 0.01% 826
2021
Q1
Sell
-2,551
Closed -$255K 418
2020
Q4
$255K Buy
+2,551
New +$270K 0.05% 328
2020
Q1
Sell
-2,043
Closed -$204K 390
2019
Q4
$204K Buy
+2,043
New +$192K 0.02% 537

Other funds holding AZN

Sunbelt Securities's AZN Position: Q1 2026 in Review

Sunbelt Securities reduced its AstraZeneca (AZN) stake by 2.5% in Q1 2026, selling an estimated $26.4K and leaving 5,357 shares worth $1.06M. The position accounts for 0.07% of the portfolio, ranked #245.

Sunbelt Securities first reported a position in AZN in Q4 2019 and has held it in 15 quarters since. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Sunbelt Securities held 5,357 shares of AstraZeneca worth $1.06M as of Q1 2026.
  • Sunbelt Securities sold 137 AstraZeneca shares in Q1 2026, an estimated $26.4K.
  • AstraZeneca made up 0.07% of Sunbelt Securities's portfolio in Q1 2026, its #245 holding.
  • Sunbelt Securities first reported a position in AstraZeneca in Q4 2019 and has held it in 15 quarters since.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.